{"id":"W2911017829","doi":"10.1136/bmjopen-2018-023765","title":"Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial","year":2019,"lang":"en","type":"article","venue":"BMJ Open","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Efficacy and Mechanism Evaluation Programme; Medical Research Council; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Clinical trial; Colectomy; Ulcerative colitis; Placebo; Internal medicine; Infliximab; Randomized controlled trial; Clinical endpoint; Incidence (geometry); Anakinra; Disease; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002585988,0.0002645641,0.0007657355,0.00006413569,0.00009501549,0.0001069365,0.0006364601,0.0002432292,0.00007861434],"category_scores_gemma":[0.0003966411,0.0001877836,0.000327804,0.00006583443,0.00008350726,0.00001953398,0.0004802771,0.0001235371,0.00000289992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002531826,"about_ca_system_score_gemma":0.0008568239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002306382,"about_ca_topic_score_gemma":0.0001169157,"domain_scores_codex":[0.9975176,0.0005203906,0.0009645986,0.0004620147,0.0002180318,0.0003172983],"domain_scores_gemma":[0.9984751,0.0001560014,0.0005252486,0.0006416009,0.000100958,0.00010111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9918305,0.0008528157,0.000008384885,0.00008672513,0.0003735269,0.00001558956,0.0001272192,0.000007686833,0.004196932,0.00004462605,0.002155628,0.0003003977],"study_design_scores_gemma":[0.9824346,0.008366197,0.00001277469,0.00009036998,0.0001461714,0.000005230521,0.00007423179,0.0001575571,0.004087796,0.00007337968,0.004283706,0.0002679345],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.5235962,0.000001794407,0.000005146523,0.00009039232,0.0001832333,0.4752681,0.00005854139,0.000004017324,0.0007925199],"genre_scores_gemma":[0.1846924,9.805274e-7,0.00007409724,0.0001169057,0.000619108,0.8120899,0.00008297795,0.00003271776,0.002290935],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.3389039,"threshold_uncertainty_score":0.7657592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04509148158752204,"score_gpt":0.3993428257761475,"score_spread":0.3542513441886255,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}